Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine

Toxicology

Volumn 229, Issue 1-2, 2007, Pages 157-164

  Gaber, Kerstin ^a   Harréus, Ulrich A ^a   Matthias, Christoph ^a   Kleinsasser, Norbert H ^b   Richter, Elmar ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Hemoglobin adducts; Local anesthesia; o Toluidine; Prilocaine

Indexed keywords

2 METHYLANILINE; 4 BIPHENYLAMINE; AROMATIC AMINE; CARCINOGEN; HEMOGLOBIN; LOCAL ANESTHETIC AGENT; PRILOCAINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HEAD AND NECK SURGERY; HUMAN; LOCAL ANESTHESIA; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINOBIPHENYL COMPOUNDS; ANESTHETICS, LOCAL; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEMOGLOBINS; HUMANS; INJECTIONS, SUBCUTANEOUS; LINEAR MODELS; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; PRILOCAINE; SMOKING; TOLUIDINES; URINARY BLADDER NEOPLASMS;

EID: 33845316103     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.10.012     Document Type: Article

References (47)

1. Airoldi L., Orsi F., Magagnotti C., Coda R., Randone D., Casetta G., Peluso M., Hautefeuille A., Malaveille C., and Vineis P. Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies. Carcinogenesis 23 (2002) 861-866
2. Åkerman B., Åström A., Ross S., and Telc A. Studies on the absorption, distribution and metabolism of labelled prilocaine and lidocaine in some animal species. Acta Pharmacol. Toxicol. 24 (1966) 389-403
3. Arthur G.R., Scott D.H., Boyes R.N., and Scott D.B. Pharmacokinetic and clinical pharmacological studies with mepivacaine and prilocaine. Br. J. Anaesth. 51 (1979) 481-485
4. Benowitz N.L., Peng M., and Jacob P. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism. Clin. Pharmacol. Ther. 74 (2003) 468-474
5. Bryant M.S., Simmons H.F., Harrell R.E., and Hinson J.A. 2,6-Dimethylaniline-hemoglobin adducts from lidocaine in humans. Carcinogenesis 15 (1994) 2287-2290
6. Buckley M.M., and Benfield P. Eutectic lidocaine/prilocaine cream. A review of the topical anaesthetic/analgesic efficacy of a eutectic mixture of local anaesthetics (EMLA). Drugs 46 (1993) 126-151
7. Castelao J.E., Yuan J.-M., Skipper P.L., Tannenbaum S.R., Gago-Dominguez M., Crowder J.S., Ross R.K., and Yu M.C. Gender- and smoking-related bladder cancer risk. J. Natl. Cancer Inst. 93 (2001) 538-545
8. DeBord D.G., Swearengin T.F., Cheever K.L., Booth-Jones A.D., and Wissinger L.A. Binding characteristics of ortho-toluidine to rat hemoglobin and albumin. Arch. Toxicol. 66 (1992) 231-236
9. Deutsche Forschungsgemeinschaft. MAK- und BAT-Werte-Liste. Mitteilung 42 der Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe (2006), Wiley/VCH Verlag GmbH & Co.KGaA, Weinheim, Germany
10. de Weert K., Traksel M., Gielen M., Slappendel R., Weber E., and Dirksen R. The incidence of transient neurological symptoms after spinal anaesthesia with lidocaine compared to prilocaine. Anaesthesia 55 (2000) 1020-1024
11. Eidelman A., Weiss J.M., Lau J., and Carr D.B. Topical anesthetics for dermal instrumentation: a systematic review of randomized, controlled trials. Ann. Emerg. Med. 46 (2005) 343-351
12. ®, a new intrapocket anesthetic, in patients with advanced periodontitis. J. Clin. Periodontol. 28 (2001) 425-429
13. Gan J., Skipper P.L., and Tannenbaum S.R. Oxidation of 2,6-dimethylaniline by recombinant human cytochrome P450s and human liver microsomes. Chem. Res. Toxicol. 14 (2001) 672-677
14. ® in patients with generalized periodontitis: effect on blood methemoglobin and tolerability. Acta Odontol. Scand. 61 (2003) 230-234
15. Hjelm M., Ragnarsson B., and Wistrand P. Biochemical effects of aromatic compounds. III Ferrihaemoglobinaemia and the presence of p-hydroxy-o-toluidine in human blood after the administration of prilocaine. Biochem. Pharmacol. 21 (1972) 2825-2834
16. IARC, 2000. Some industrial chemicals. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 77. International Agency for Research on Cancer, Lyon, France, pp. 1-564.
17. Jodynis-Liebert J., and Matuszewska A. Effect of toluidines and dinitrotoluenes on caffeine metabolic rate in rat. Toxicol. Lett. 104 (1999) 159-165
18. Kalow W. Pharmacogenetics in biological perspective. Pharmacol. Rev. 49 (1997) 369-379
19. Klein J., Fernandes D., Gazarian M., Kent G., and Koren G. Simultaneous determination of lidocaine, prilocaine and the prilocaine metabolite o-toluidine in plasma by high-performance liquid chromatography. J. Chromatogr. B 655 (1994) 83-88
20. Klein J.A. The tumescent technique for liposuction surgery. Am. J. Cosmet. Surg. 4 (1987) 263-267
21. Kutzer C., Branner B., Zwickenpflug W., and Richter E. Simultaneous solid-phase extraction and gas chromatographic-mass spectrometric determination of hemoglobin adducts from tobacco-specific nitrosamines and aromatic amines. J. Chromatogr. Sci. 35 (1997) 1-6
22. Lener E.V., Bucalo B.D., Kist D.A., and Moy R.L. Topical anesthetic agents in dermatologic surgery. A review. Dermatol. Surg. 23 (1997) 673-683
23. Lewalter J., and Gries W. Haemoglobin adducts of aromatic amines: aniline, o-, m- and p-toluidine, o-anisidine, p-chloroaniline, α-and β-naphthylamine, 4-aminodiphenyl, benzidine, 4,4′-diaminodiphenylmethane, 3,3′-dichlorobenzidine. In: Greim H. (Ed). Analyses of Hazardous Substances in Biological Materials (2000), Wiley/VCH Verlag GmbH, Weinheim, Germany 191-218
24. Lindenblatt N., Belusa L., Tiefenbach B., Schareck W., and Olbrisch R.R. Prilocaine plasma levels and methemoglobinemia in patients undergoing tumescent liposuction involving less than 2000 ml. Aesth. Plast. Surg. 28 (2004) 435-440
25. Lok C., Paul C., Amblard P., Bessis D., Debure C., Faivre B., Guillot B., Ortonne J.P., Huledal G., and Kalis B. EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: a double-blind, placebo-controlled study. J. Am. Acad. Dermatol. 40 (1999) 208-213
26. Markowitz S.B. Corrections to: Markowitz, S.B., Levin, K. Continued epidemic of bladder cancer in workers exposed to ortho-toluidine in a chemical factory. J. Occup. Environ. Med. 47 (2005) 875-877
27. Markowitz S.B., and Levin K. Continued epidemic of bladder cancer in workers exposed to ortho-toluidine in a chemical factory. J. Occup. Environ. Med. 46 (2004) 154-160
28. Patrianakos C., and Hoffmann D. Chemical studies on tobacco smoke LXIV On the analysis of aromatic amines in cigarette smoke. J. Anal. Toxicol. 3 (1979) 150-154
29. Richter E., and Branner B. Biomonitoring of exposure to aromatic amines: haemoglobin adducts in humans. J. Chromatogr. B 778 (2002) 49-62
30. Rubino G.F., Scansetti G., Piolatto G., and Pira E. The carcinogenic effect of aromatic amines: an epidemiological study on the role of o-toluidine and 4,4′-methylene bis(2-methylaniline) in inducing bladder cancer in man. Environ. Res. 27 (1982) 241-254
31. Sabbioni G., and Richter E. Aromatic amines, nitroarenes, and heterocyclic amines. In: Marquardt H., Schäfer S.G., McClellan R., and Welch F. (Eds). Toxicology (1999), Academic Press, San Diego, CA, USA 174-729
32. Sellers C., and Markowitz S. Reevaluating the carcinogenicity of ortho-toluidine: a new conclusion and its implications. Regul. Toxicol. Pharmacol. 16 (1992) 301-317
33. Skipper P.L., and Tannenbaum S.R. Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11 (1990) 507-518
34. Smith C.J., Dooly G.L., and Moldoveanu S.C. New technique using solid-phase extraction for the analysis of aromatic amines in mainstream cigarette smoke. J. Chromatogr. A 991 (2003) 99-107
35. Söderberg L., Dyhre H., Roth B., and Björkman S. Ultralong peripheral nerve block by lidocaine:prilocaine 1:1 mixture in a lipid depot formulation: comparison of in vitro, in vivo, and effect kinetics. Anesthesiology 104 (2006) 110-121
36. 14C]toluidine in the F344 rat. Xenobiotica 10 (1980) 457-468
37. Stiborová M., Miksanová M., Sulc M., Rýdlová H., Schmeiser H.H., and Frei E. Identification of a genotoxic mechanism for the carcinogenicity of the environmental pollutant and suspected human carcinogen o-anisidine. Int. J. Cancer 116 (2005) 667-678
38. ®) to leg ulcers. Br. J. Dermatol. 145 (2001) 530-534
39. Tak J.H., and van Bon W.H. Pain- and distress-reducing interventions for venepuncture in children. Child Care Health Dev. 32 (2006) 257-268
40. Talaska G. Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology. J. Environ. Sci. Health C21 (2003) 29-43
41. Talaska G., Schamer M., Casetta G., Tizzani A., and Vineis P. Carcinogen-DNA adducts in bladder biopsies and urothelial cells: a risk assessment exercise. Cancer Lett. 84 (1994) 93-97
42. Talaska G., Schamer M., Skipper P., Tannenbaum S., Caporaso N., Unruh L., Kadlubar F.F., Bartsch H., Malaveille C., and Vineis P. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol. Biomarkers Prev. 1 (1991) 61-66
43. van der Meer A.D., Burm A.G., Stienstra R., van Kleef J.W., Vletter A.A., and Olieman W. Pharmacokinetics of prilocaine after intravenous administration in volunteers: enantioselectivity. Anesthesiology 90 (1999) 988-992
44. Vineis P., Alavanja M., and Garte S. Dose-response relationship in tobacco-related cancers of bladder and lung: a biochemical interpretation. Int. J. Cancer 108 (2004) 2-7
45. Ward E., Carpenter A., Markowitz S., Roberts D., and Halperins W. Excess numbers of bladder cancers in workers exposed to ortho-toluidine and aniline. J. Natl. Cancer Inst. 83 (1991) 501-506
46. Ward E.M., Sabbioni G., DeBord D.G., Teass A.W., Brown K.K., Talaska G.G., Roberts D.R., Ruder A.M., and Streicher R.P. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess. J. Natl. Cancer Inst. 88 (1996) 1046-1052
47. ® (particularly for epidural anaesthesia). Acta Anaesth. Scand. Suppl. 16 (1965) 249-256